Oxurion NV (OXURION) aksje
OXUR.BR
Stengt€0.0030-0.0006 (-16.67%)
Laster graf...
OXURION
Market Cap
$333,148
Åpning0.0036
Høy0.0036
Lav0.0030
Volum1.67M
P/EN/A
Markedsverdi333.15k
52-ukers høy0.0840
52-ukers lav0.0030
Gj.sn. volum707.39k
UtbytteN/A
Beta-0.15
EPS-0.1300
Om Oxurion NV (OXURION) aksje
Oxurion NV, a biopharmaceutical company, develops medicines to prevent blindness in Belgium. The company is developing ophthalmic treatments to preserve vision for patients with retinal disorders, including geographic atrophy and age-related macular degeneration. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium.
Selskapsinformasjon
Børs: Brussels (BRU)
Sektor: Sundhed
Industri: Bioteknologi
Adresse:
Gaston Geenslaan 1
3001 Leuven, Belgium
3001 Leuven, Belgium
Telefon: + 32 1 675 13 10
Nettside: https://www.oxurion.com
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Laveste kursmål
Gjennomsnittlig kursmål
Median kursmål
Høyeste kursmål